Effect of second-generation antipsychotics on brain network topology in first-episode schizophrenia: A longitudinal rs-fMRI study

We aimed to evaluate the functional network properties in first-episode schizophrenia (SZ) patients at baseline and after 4-months treatment with second-generation antipsychotic drugs. Resting-state functional magnetic resonance imaging and graph theory approaches were utilized to evaluate the funct...

Full description

Saved in:
Bibliographic Details
Published inSchizophrenia research Vol. 208; pp. 160 - 166
Main Authors Wang, Liu-Xian, Guo, Fan, Zhu, Yuan-Qiang, Wang, Hua-Ning, Liu, Wen-Ming, Li, Chen, Wang, Xing-Rui, Cui, Long-Biao, Xi, Yi-Bin, Yin, Hong
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.06.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We aimed to evaluate the functional network properties in first-episode schizophrenia (SZ) patients at baseline and after 4-months treatment with second-generation antipsychotic drugs. Resting-state functional magnetic resonance imaging and graph theory approaches were utilized to evaluate the functional integration and segregation of brain networks in 36 first-episode patients (20 male/16 female) with SZ and 36 age and sex matched healthy controls (20 male/16 female). Compared with healthy controls, SZ at baseline showed lower clustering coefficient (Cp) and local network efficiency (Eloc), and this abnormal pattern was modulated with treatment of antipsychotic drugs at follow-up. Longitudinally, the increase of Cp was associated with the improvement of negative symptom. We found that the strength of functional connectivity between brain regions were significantly increased in three connections after treatment, mainly involving the frontal, parietal and occipital lobes. The current study suggested that antipsychotic drugs could modulate the faulty local clustering of the functional connectome in SZ. Furthermore, Cp, the parameter that reflects local clustering of topological organization, demonstrated the potential to be a connectome-based biomarker of treatment response to second-generation antipsychotics in patients with SZ.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0920-9964
1573-2509
DOI:10.1016/j.schres.2019.03.015